Development of real-time fluorescent reverse transcription loop-mediated isothermal amplification assays for rhinovirus detection.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
07 2019
Historique:
received: 04 10 2018
revised: 06 02 2019
accepted: 06 02 2019
pubmed: 9 2 2019
medline: 10 4 2020
entrez: 9 2 2019
Statut: ppublish

Résumé

Human rhinoviruses (RVs) belong to the genus Enterovirus of the family Picornaviridae, and are classified into RV-A, -B, and -C species. Two assays were developed to detect RVs by a real-time fluorescent reverse transcription loop-mediated isothermal amplification method: one was designed based on the 5'-untranslated regions (UTRs) of RV-A and -B, and the other was designed based on the 5'-UTR of RV-C. The competence of both assays for the diagnosis of RV infection was tested using isolated viruses and compared with real-time reverse transcription polymerase chain reaction assays on clinical specimens. Neither assay demonstrated cross-reactivity with other tested enteroviruses, and they detected 19 out of 21 tested RV-As and seven out of eight tested RV-Cs. The specificity of the assays was 100% for the detection of RVs and their sensitivity for RV-A and RV-C was 86.3% and 77.3%, respectively, on clinical specimens by the combined use of both assays. Considering that both developed assays were highly specific and detected the majority of recently circulating RVs, they are helpful for the diagnosis of RV infection. Consequently, the results generated by these assays will enhance the surveillance of respiratory illness and the study of the roles of RVs associated with clinical features and disease severity.

Identifiants

pubmed: 30735248
doi: 10.1002/jmv.25427
pmc: PMC7166982
doi:

Substances chimiques

5' Untranslated Regions 0
DNA Primers 0
RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1232-1238

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

J Virol Methods. 2019 May;267:53-58
pubmed: 30831121
J Virol Methods. 2019 Jan;263:75-80
pubmed: 30347198
Am J Respir Crit Care Med. 2011 Mar 15;183(6):734-42
pubmed: 20889904
J Mol Diagn. 2010 Jan;12(1):102-8
pubmed: 19948820
Emerg Infect Dis. 2011 Feb;17(2):296-8
pubmed: 21291610
J Virol Methods. 1998 Apr;71(2):197-209
pubmed: 9626953
J Med Virol. 2011 Jan;83(1):10-5
pubmed: 21108334
PLoS Negl Trop Dis. 2012;6(6):e1572
pubmed: 22745836
J Infect Dis. 2018 Aug 14;218(6):848-855
pubmed: 29684211
J Med Virol. 2019 Jul;91(7):1232-1238
pubmed: 30735248
Clin Microbiol Rev. 2013 Jan;26(1):135-62
pubmed: 23297263
Science. 2009 Apr 3;324(5923):55-9
pubmed: 19213880
J Allergy Clin Immunol. 2017 Oct;140(4):895-906
pubmed: 28987219
J Infect Dis. 2006 Nov 15;194(10):1398-402
pubmed: 17054069
Nature. 1991 Mar 7;350(6313):91-2
pubmed: 1706072
Open Forum Infect Dis. 2016 Jan 13;3(1):ofw001
pubmed: 26900577
Nucleic Acids Res. 2000 Jun 15;28(12):E63
pubmed: 10871386
J Clin Microbiol. 2006 Jan;44(1):166-71
pubmed: 16390965
J Clin Virol. 2015 Mar;64:74-82
pubmed: 25728083
Jpn J Infect Dis. 2014;67(6):469-75
pubmed: 25410563
Virology. 1987 Jul;159(1):191-2
pubmed: 3037780
J Clin Microbiol. 2003 May;41(5):1971-6
pubmed: 12734236
J Clin Microbiol. 1998 Feb;36(2):539-42
pubmed: 9466772
Pediatr Infect Dis J. 2009 Apr;28(4):337-9
pubmed: 19258921
J Gen Virol. 2013 Aug;94(Pt 8):1791-1806
pubmed: 23677786
J Med Virol. 2006 Sep;78(9):1232-40
pubmed: 16847968
J Clin Microbiol. 2009 Jun;47(6):1742-9
pubmed: 19339471
Mol Cell Probes. 2002 Jun;16(3):223-9
pubmed: 12144774
Virology. 1991 Feb;180(2):814-7
pubmed: 1846502
Clin Infect Dis. 2005 Jul 15;41(2):262-5
pubmed: 15983926
Nat Protoc. 2008;3(5):877-82
pubmed: 18451795
J Virol Methods. 2018 Aug;258:41-48
pubmed: 29763640
J Virol Methods. 2011 Jan;171(1):156-62
pubmed: 21029748
J Microbiol. 2015 Jan;53(1):1-5
pubmed: 25557475
Mol Biotechnol. 2012 Mar;50(3):221-8
pubmed: 21728031
J Virol. 1990 Mar;64(3):1117-23
pubmed: 2154596
Curr Opin Virol. 2012 Jun;2(3):287-93
pubmed: 22542099

Auteurs

Mina Nakauchi (M)

Influenza Virus Research Center, National Institute of Infectious Diseases, Gakuen, Musashimuyayama-shi, Tokyo, Japan.

Ikuyo Takayama (I)

Influenza Virus Research Center, National Institute of Infectious Diseases, Gakuen, Musashimuyayama-shi, Tokyo, Japan.

Hitoshi Takahashi (H)

Influenza Virus Research Center, National Institute of Infectious Diseases, Gakuen, Musashimuyayama-shi, Tokyo, Japan.

Shohei Semba (S)

Eiken Chemical Co, Ltd, Taito, Taito-ku, Tokyo, Japan.

Shinji Saito (S)

Influenza Virus Research Center, National Institute of Infectious Diseases, Gakuen, Musashimuyayama-shi, Tokyo, Japan.

Hideyuki Kubo (H)

Division of Microbiology, Osaka Institute of Public Health, Tojo-cho, Tennoji-ku, Osaka, Japan.

Atsushi Kaida (A)

Division of Microbiology, Osaka Institute of Public Health, Tojo-cho, Tennoji-ku, Osaka, Japan.

Kunihiro Oba (K)

Department of Pediatrics, Showa General Hospital, Hanakoganei, Kodaira-shi, Tokyo, Japan.

Shiho Nagata (S)

Influenza Virus Research Center, National Institute of Infectious Diseases, Gakuen, Musashimuyayama-shi, Tokyo, Japan.

Takato Odagiri (T)

Influenza Virus Research Center, National Institute of Infectious Diseases, Gakuen, Musashimuyayama-shi, Tokyo, Japan.

Tsutomu Kageyama (T)

Influenza Virus Research Center, National Institute of Infectious Diseases, Gakuen, Musashimuyayama-shi, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH